Sinonasal outcomes associated with the use of BioGlue® in endoscopic transsphenoidal pituitary surgery.

Hannan, Cathal John; Nolan, Deirdre; Corr, Paula; Amoo, Michael; Murray, Daniel; Looby, Seamus; Javadpour, Mohsen

Hannan, Cathal John; Nolan, Deirdre; Corr, Paula; Amoo, Michael; Murray, Daniel; Looby, Seamus; Javadpour, Mohsen.

Affiliation

Hannan CJ; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Manchester, England.
Nolan D; National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.
Corr P; National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.
Amoo M; National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.
Murray D; Royal College of Surgeons in Ireland, Dublin, Ireland.
Looby S; National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.
Javadpour M; Royal College of Surgeons in Ireland, Dublin, Ireland.

Neurosurg Rev ; 45(3): 2249-2256, 2022 Jun.

Article in En | MEDLINE | ID: mdl-35083593

Subject(s)

Pituitary Diseases; Pituitary Neoplasms; Sinusitis; Endoscopy/methods; Humans; Pituitary Gland/surgery; Pituitary Neoplasms/surgery; Postoperative Complications/epidemiology; Postoperative Complications/etiology; Proteins; Sinusitis/complications; Sinusitis/surgery; Treatment Outcome

Key words

BioGlue®; Endoscopic surgery; Patient-reported outcome measures; Pituitary; Sinusitis; Skull base repair; Tissue sealant

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Diseases / Pituitary Neoplasms / Sinusitis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Neurosurg Rev Year: 2022 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google